Abstract: Epithelial-to-mesenchymal transition (EMT) is a key biological process that facilitates cancer metastasis to distant organs. Most preclinical studies investigating EMT are conducted using traditional two-dimensional (2D) culture models, which fail to recapitulate the in vivo tumor microenvironment, limiting the translational relevance of their findings to clinical settings. Consequently, three-dimensional (3D) culture systems have emerged […]
Abstract: Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and the second leading cause of cancer death in the United States of America. Organoids, specifically CRC organoids have emerged as a powerful preclinical model as they closely recapitulate patient-specific tumor features, including tumor morphology, genetics, and treatment response. However, most organoid culture systems […]
Eligibility & Submission Rules: Applicants may submit only one entry per person for this travel award. Submissions for multiple events are not permitted and will result in disqualification. Duplicate entries (e.g., submissions under different email addresses) will be voided. Four (4) applicants will be selected randomly per event. Terms and Conditions Apply. To apply, please […]
Inside SLAS2026: Key Highlights, Connections, and Innovations SLAS2026 was an energizing week of scientific exchange, meaningful conversations, and hands-on demonstrations for the team at TheWell Bioscience. The event offered an invaluable opportunity to connect with researchers and partners, explore the evolving needs in automated 3D cell culture and organoid research, and showcase how TheWell Bioscience’s […]
Advancing Automated 3D Cell Culture with an End-to-End Xeno-Free Platform at SLAS 2026! TheWell Bioscience will attend SLAS 2026 (Society for Laboratory Automation and Screening), the premier international conference and exhibition for laboratory automation, screening, and life sciences innovation, taking place February 9–11, 2026, at the Thomas Michael Menino Convention & Exhibition Center (MCEC) in […]
SfN Neuroscience 2025 Recap: A Week of Innovation, Collaboration, and Discovery
Abstract: Human induced pluripotent stem cells (iPSCs) offer a powerful starting point to study the molecular dynamics of the developing nervous system. Further, they provide an invaluable tool for developing patient-specific models to study the disease process. Therefore, optimizing their growth in a defined, native 3D state is of paramount importance to both guide and […]
Abstract: The development of in vitro systems for long-term neuronal differentiation and survival is crucial for understanding both physiological processes and various disease states. While traditional two-dimensional (2D) neuron models have been instrumental in neuroscience research, these systems fail to maintain neuron viability over extended periods, impeding prolonged neuronal maturation. One reason for this limitation is that 2D-based models misrepresent […]
Discover the Future of 3D Cell Culture at SfN – Neuroscience 2025 We’re excited to announce our first-ever participation at Neuroscience 2025! Join us on November 15–19, 2025, at the San Diego Convention Center to explore how VitroGel®, our xeno-free, synthetic hydrogel system, is driving the shift toward animal-free, reproducible, and scalable 3D cell culture […]
Abstract: Tamoxifen, an anti-oestrogen, is the only licensed medication in the UK for breast cancer prevention in high-risk, pre-menopausal women. Data from the Biomarkers of Breast Cancer Prevention (BBCP) trial show that, while tamoxifen reduces overall proliferation after three months of treatment, a subset of women (5/13) show stable or increased proliferation. As proliferation is […]
